IMCR logo

Immunocore Holdings plc (IMCR) Cash From Financing

Annual CFF:

$343.88M+$309.54M(+901.23%)
December 31, 2024

Summary

  • As of today, IMCR annual cash from financing is $343.88 million, with the most recent change of +$309.54 million (+901.23%) on December 31, 2024.
  • During the last 3 years, IMCR annual cash from financing has risen by +$55.70 million (+19.33%).
  • IMCR annual cash from financing is now at all-time high.

Performance

IMCR Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

Quarterly CFF:

$1.84M-$1.87M(-50.41%)
September 30, 2025

Summary

  • As of today, IMCR quarterly cash from financing is $1.84 million, with the most recent change of -$1.87 million (-50.41%) on September 30, 2025.
  • Over the past year, IMCR quarterly cash from financing has dropped by -$9700.00 (-0.52%).
  • IMCR quarterly cash from financing is now -99.53% below its all-time high of $395.79 million, reached on March 31, 2024.

Performance

IMCR Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

TTM CFF:

-$45.03M-$9700.00(-0.02%)
September 30, 2025

Summary

  • As of today, IMCR TTM cash from financing is -$45.03 million, with the most recent change of -$9700.00 (-0.02%) on September 30, 2025.
  • Over the past year, IMCR TTM cash from financing has dropped by -$449.92 million (-111.12%).
  • IMCR TTM cash from financing is now -110.62% below its all-time high of $424.07 million, reached on March 31, 2024.

Performance

IMCR TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMCRcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

IMCR Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+901.2%-0.5%-111.1%
3Y3 Years+19.3%-98.8%-130.3%
5Y5 Years+375.8%+10000.0%-10000.0%

IMCR Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+901.2%-99.5%+103.5%-110.6%+8.5%
5Y5-Yearat high+901.2%-99.5%+103.5%-110.6%+8.5%
All-TimeAll-Timeat high>+9999.0%-99.5%+103.5%-110.6%+8.5%

IMCR Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.84M(-50.4%)
-$45.03M(-0.0%)
Jun 2025
-
$3.71M(+45.0%)
-$45.02M(+8.5%)
Mar 2025
-
$2.56M(+104.8%)
-$49.20M(-114.3%)
Dec 2024
$343.88M(+901.2%)
-$53.14M(-2970.5%)
$344.03M(-15.0%)
Sep 2024
-
$1.85M(+495.6%)
$404.89M(-1.7%)
Jun 2024
-
-$468.00K(-100.1%)
$411.97M(-2.9%)
Mar 2024
-
$395.79M(+5026.3%)
$424.07M(+1129.9%)
Dec 2023
$34.35M(-76.4%)
$7.72M(-13.5%)
$34.48M(+99.7%)
Sep 2023
-
$8.93M(-23.2%)
$17.27M(-89.1%)
Jun 2023
-
$11.63M(+87.8%)
$157.76M(+7.5%)
Mar 2023
-
$6.19M(+165.3%)
$146.70M(+4.9%)
DateAnnualQuarterlyTTM
Dec 2022
$145.44M(-49.5%)
-$9.49M(-106.4%)
$139.85M(-6.0%)
Sep 2022
-
$149.42M(>+9900.0%)
$148.79M(+3137.6%)
Jun 2022
-
$578.00K(+187.2%)
-$4.90M(-31.1%)
Mar 2022
-
-$662.50K(-21.4%)
-$3.74M(-101.3%)
Dec 2021
$288.19M(+82.4%)
-$545.70K(+87.2%)
$286.75M(-30.8%)
Sep 2021
-
-$4.27M(-345.2%)
$414.46M(-1.0%)
Jun 2021
-
$1.74M(-99.4%)
$418.73M(+0.4%)
Mar 2021
-
$289.82M(+127.9%)
$416.99M(+227.9%)
Dec 2020
$158.01M(+118.6%)
$127.16M(>+9900.0%)
$127.17M(>+9900.0%)
Sep 2020
-
$5900.00
$5900.00
Dec 2019
$72.28M(>+9900.0%)
-
-
Dec 2018
$128.20K
-
-

FAQ

  • What is Immunocore Holdings plc annual cash from financing?
  • What is the all-time high annual cash from financing for Immunocore Holdings plc?
  • What is Immunocore Holdings plc annual cash from financing year-on-year change?
  • What is Immunocore Holdings plc quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Immunocore Holdings plc?
  • What is Immunocore Holdings plc quarterly cash from financing year-on-year change?
  • What is Immunocore Holdings plc TTM cash from financing?
  • What is the all-time high TTM cash from financing for Immunocore Holdings plc?
  • What is Immunocore Holdings plc TTM cash from financing year-on-year change?

What is Immunocore Holdings plc annual cash from financing?

The current annual cash from financing of IMCR is $343.88M

What is the all-time high annual cash from financing for Immunocore Holdings plc?

Immunocore Holdings plc all-time high annual cash from financing is $343.88M

What is Immunocore Holdings plc annual cash from financing year-on-year change?

Over the past year, IMCR annual cash from financing has changed by +$309.54M (+901.23%)

What is Immunocore Holdings plc quarterly cash from financing?

The current quarterly cash from financing of IMCR is $1.84M

What is the all-time high quarterly cash from financing for Immunocore Holdings plc?

Immunocore Holdings plc all-time high quarterly cash from financing is $395.79M

What is Immunocore Holdings plc quarterly cash from financing year-on-year change?

Over the past year, IMCR quarterly cash from financing has changed by -$9700.00 (-0.52%)

What is Immunocore Holdings plc TTM cash from financing?

The current TTM cash from financing of IMCR is -$45.03M

What is the all-time high TTM cash from financing for Immunocore Holdings plc?

Immunocore Holdings plc all-time high TTM cash from financing is $424.07M

What is Immunocore Holdings plc TTM cash from financing year-on-year change?

Over the past year, IMCR TTM cash from financing has changed by -$449.92M (-111.12%)
On this page